Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists

INTRODUCTION: Uptake of neoadjuvant chemotherapy (NC) for muscle invasive bladder cancer (MIBC) has been low despite evidence of a survival benefit. The primary aim of this study was to better understand why the rates are low and determine what factors specifically influence the decision to recommen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hsu, Tina, Black, Peter C., Chi, Kim N., Canil, Christina M., Eigl, Bernhard J., Kulkarni, Girish, North, Scott, Wood, Lori, Zlotta, Alexandre R., Lau, Anthea, Panzarella, Tony, Sridhar, Srikala S.
Format: Artigo
Idioma:Inglês
Publicat: Canadian Medical Association 2014
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4216285/
https://ncbi.nlm.nih.gov/pubmed/25408794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2111
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars